Dr Reddy's Second-Quarter Profit Jumps Nearly 70% To 518 Crore Rupees

Dr.Reddy's Laboratories posted a better-than-expected rise in second-quarter profit as higher sales in some emerging countries offset a marginal decline in business in North America, a key market for the Indian generic drugmaker. Dr.Reddy's net profit soared 69.7 per cent to Rs 518 crore in the quarter ended September 30, well ahead of analysts' expectations of Rs 352 crore, according to Refinitiv data. Revenue in the global generics...